Simplifying Global Compliance
FDAnews Drug Daily Bulletin
RegeneRx Drug Promotes Recovery of Peripheral Neuropathy in Type II Diabetic Mice
Aug. 30, 2012
RegeneRx Biopharmaceuticals reports that U.S. researchers have found that Thymosin Beta 4 promotes statistically significant recovery of peripheral neuropathy in type II diabetic mice including recovery of neurovascular dysfunction in the sciatic nerve and recovery of neurological function.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing